The global plasma therapy market size was US$ 380.32 million in 2021. The global plasma therapy market size is forecast to reach US$ 798.1 million by 2030, growing at a compound annual growth rate (CAGR) of 8.6% during the forecast period from 2022 to 2030.
Blood plasma contains platelets, autologous platelets, and cytokines, which are helpful in healing soft tissues. A traditional technique widely used in dentistry, dermatology, and orthopedics is plasma therapy. There are many applications of plasma therapy, such as wound healing and the treatment of androgenetic alopecia. A primary aim of plasma therapy is to transfer a healthy individual's immunity to a patient. Plasma usually contains high levels of antibodies that aid in curing disease.
Factors Influencing Market Growth
Impact Analysis of COVID-19
The COVID-19 pandemic had a positive impact on the global plasma therapy market. The Food and Drug Administration (FDA) granted an emergency use authorization (EUA) on August 23, 2020, allowing the administration of COVID-19 convalescent plasma to hospitalized patients with COVID-19 disease. A patient who recovered from COVID-19 used plasma from the body of another who was also suffering from COVID-19. In the event of a pandemic, convalescent plasma might prove to be an effective treatment option. Therefore, more patients with autoimmune diseases and inflammatory disorders undergoing treatment procedures with plasma-derived immunoglobulin have boosted the global market growth.
Regional Insights
During the forecast period, North America is forecast to account for the largest share in the global plasma therapy market. The market in the region is forecast to grow in the coming years as a result of research and development carried out by the government and private sectors.
The Asia Pacific region is forecast for considerable growth during the forecast period. The rise in awareness and the increase in population has led to an increase in blood donations. As the number of hospitals and clinics increases and advanced plasma therapies becomes available, the plasma therapy market will grow.
Leading Competitors
The leading prominent companies profiled in the global plasma therapy market are:
Scope of the Report
The global plasma therapy market segmentation focuses on Type, Application, End-User, and Region.
Segmentation based on Type
Segmentation based on Application
Segmentation based on End-User
Segmentation based on Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL PLASMA THERAPY MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
4 GLOBAL PLASMA THERAPY MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS
5 GLOBAL PLASMA THERAPY MARKET, BY TYPE
5.1 OVERVIEW
5.2 PURE PLATELET-RICH PLASMA (PRP)
5.3 LEUKOCYTE-RICH PRP
5.4 PURE PLATELET-RICH FIBRIN
5.5 LEUKOCYTE-RICH FIBRIN
6 GLOBAL PLASMA THERAPY MARKET, BY APPLICATION
6.1 OVERVIEW
6.2 ORTHOPEDICS
6.3 DERMATOLOGY
6.4 DENTISTRY
6.5 OTHERS
7 GLOBAL PLASMA THERAPY MARKET, BY END-USER
7.1 OVERVIEW
7.2 HOSPITALS
7.3 DERMATOLOGY CLINICS
7.4 OTHERS
8 GLOBAL PLASMA THERAPY MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3. 1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL PLASMA THERAPY MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
10 COMPANY PROFILES
10.1 THE MTF BIOLOGICS
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.2 REGEN LAB SA
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.3 ARTHREX, TERUMO CORPORATION
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.4 ZIMMER BIOMET
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.5 JOHNSON & JOHNSON (DEPUY SYNTHES)
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.6 EXACTECH, INCORPORATED
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.7 ONY BIOTECH INCORPORATED
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.8 PFIZER INCORPORATED
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.9 TEVA PHARMACEUTICAL INDUSTRIES LIMITED
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved